Value through Innovation

main navigation

jump to content to meta navigation
Press Releases

page content

jump to main navigation to meta navigation

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 next
25.07.2007 New Spiriva® Respimat® inhaler completes European approval process for COPD
25.07.2007 Data presented at International AIDS Society (IAS) conference shows long-term Viramune ® (nevirapine) efficacy and increase in good cholesterol - For medical media, outside the US only
24.07.2007 Aptivus® (tipranavir) demonstrates potent and durable treatment response in HIV-positive women - For medical media, outside the US only
24.07.2007 Boehringer Ingelheim announces first international head-to-head trial of Aptivus® (tipranavir) versus darunavir in treatment-experienced HIV-positive patients - For medical media, outside the US only
18.07.2007 EUROPEAN Porcine Circovirus (PCV-2) Annual Research Award launched by Boehringer Ingelheim
11.07.2007 Further phase III data shows dabigatran etexilate, a new oral anticoagulant, is effective and safe in preventing venous thromboembolism after orthopaedic surgery - For medical media, outside the US only
02.07.2007 A million doses of hope against Aids - For medical media, outside the US only
18.06.2007 More than half of hypertensive patients remain uncontrolled and thus at higher risk of heart attack and stroke - telmisartan may decrease this risk. - For medical media, outside the US only
18.06.2007 New study shows that telmisartan has greater renoprotective potential than losartan in hypertensive patients with type 2 diabetes - For medical media, outside the US only
14.06.2007 Boehringer Ingelheim initiates SPRING study of Aptivus® (tipranavir) in diverse group of highly treatment-experienced HIV-positive patients - For medical media, outside the US only
08.06.2007 Efficacy of Boehringer Ingelheim’s pramipexole (Mirapexin®/Sifrol®) also demonstrated in patients with daytime RLS symptoms - For medical media, outside the US only
31.05.2007 New research confirms the benefit of extended-release dipyridamole plus ASA for preventing recurrent stroke in low- and high-risk patients - For medical media, outside the US only
23.05.2007 Workplace burden of depression magnified by co-morbid fatigue and anxiety, new study shows
23.05.2007 In new study, Duloxetine was equally effective, regardless of switch method, in reducing painful symptoms in SSRI non- or partial-responders with depression
15.05.2007 Boehringer Ingelheim further intensifies fight against AIDS
10.05.2007 Boehringer Ingelheim initiates international head-to-head HIV/AIDS trial - For medical media, outside the US only
01.04.2007 Investigation of the European Commission
27.03.2007 Boehringer Ingelheim grows faster than the market once again - Spiriva®, Micardis® and Flomax®/Alna® the top products
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 next
back to top

Media Contact

Media Contact
Our media contacts

Further Media Channels

Other News & Press Releases